CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Mizuho Initiates Zentalis Pharmaceuticals at Outperform With $8 Price Target

Positive
AI Analysis

Summary

Mizuho initiated coverage of Zentalis Pharmaceuticals with an Outperform rating and $8 price target. This is a routine analyst initiation with no material clinical, regulatory, or financial news.

Importance:2/10
Sentiment:
0.60
analyst_coveragestock_ratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 17, 2026 10:34 AM

Read Original